Cyclerion Therapeutics Inc (CYCN) Price Targets From Analysts
Use the tables below to see what analysts covering Cyclerion Therapeutics Inc think about its future price and what recommendations they have for investors and traders.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
CYCN Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- Cyclerion Therapeutics Inc's number of analysts covering the stock is greater than just about none of of all US stocks.
- The variance in analysts' estimates of CYCN is lower than just about 100% of all US stocks.
- CYCN has a greater average analyst price target than 5.35% of Pharmaceutical Products stocks.
- The upside potential (average analyst target price relative to current price) of CYCN is higher than 10.85% of Pharmaceutical Products stocks.
- The NA of CYCN is greater than just about none of of all US stocks.
In the Pharmaceutical Products industry, TLGT, LFVN and BLCM are the three stocks most similar to Cyclerion Therapeutics Inc regarding the price target and analyst recommendation information presented here.
Make investment decisions regarding CYCN using the data that counts. Try POWR Ratings for free.